PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29721725-5	2018	RESULTS: In our study, the 5-year OS (p = 0.0008), DFS (p = 0.0034), and DSS (p = 0.0029) rates were significantly better in the tegafur-uracil group than in the control group.	Uracil	137-143	peripheral myelin protein 22	Homo sapiens	73-76	
29721725-8	2018	CONCLUSIONS: The result of tegafur-uracil treatment in patients with advanced oral cancer showed significant improvement in the 5-year OS, DFS, and DSS rate, while also showing a decreased distant metastasis rate.	Uracil	35-41	peripheral myelin protein 22	Homo sapiens	148-151